Deprescribing: questions for when less medicine is better care

A medicine no one remembers starting

Among a parent's bottles there is often one nobody can quite explain. It was added during a hospital stay, or for a problem that resolved, and it simply kept being refilled. Deprescribing is the name for taking a deliberate look at medicines like that. It is not about distrusting the doctors who prescribed them. It is about asking, with a clinician, whether the regimen still fits the person it belongs to.

TL;DR

• Deprescribing is a clinician-led review that may reduce or stop medicines that no longer help.
• Central-nervous-system polypharmacy, taking 3 or more CNS-active drugs, is linked to higher fall, memory, and overdose risk.
• Bring the complete list and the history of side effects, then ask what might be safely reduced.
• Never stop or taper a medicine on your own; some need a planned wind-down.
• This is preparation for a conversation, not diagnosis, dosing, or a cue to stop anything.

What deprescribing is, and is not

Deprescribing is the planned, supervised process of reviewing a person's medicines and, where it makes sense, reducing or stopping the ones that may no longer be helping. The NIA frames it as the counterweight to polypharmacy in older adults. The crucial word is supervised. Deprescribing is something a clinician does with you, often gradually, with a plan for what to watch. It is not a caregiver quietly removing a pill from the box.

The reason it matters is that medicine lists tend to grow but rarely shrink on their own. The NIA points out that more medicines mean a higher chance of side effects, and that some combinations are riskier than others. Its specific concern is central-nervous-system polypharmacy, defined as three or more CNS-active drugs, which is associated with higher rates of falls, overdoses, memory problems, and death. When a regimen drifts into that territory, a structured review is worth requesting.

What to gather before the conversation

A deprescribing review depends on a complete, honest picture, which is essentially a reconciliation exercise: the AHRQ describes medication reconciliation as comparing the current regimen against admission, transfer, and discharge orders to catch discrepancies, and an accurate, reconciled list is what makes a review possible. Assemble:

• The full medicine list: prescriptions plus over-the-counter products, vitamins, and supplements.
• What each medicine is still for, as far as anyone knows, and which were meant to be temporary.
• A history of side effects and past reactions, since the NIA recommends sharing problems like rash, breathing trouble, dizziness, or mood changes.
• Any medicine your parent already skips or struggles with, which is real-world information a clinician can use.
• A note of your parent's own goals, if they have them, such as feeling less foggy or taking fewer pills.

That last point matters. Deprescribing decisions weigh benefit against burden, and the person's priorities are part of the equation.

Questions that open the door

You do not need to argue for removing anything. You need to ask good questions and let the clinician lead. MedlinePlus encourages bringing your list and questions and writing down the plan. Useful prompts include:

• Could we review the whole list for anything that might no longer be needed?
• Is any medicine here being used to treat the side effect of another medicine?
• Are any of these the kind that act on the brain and could be adding to falls or confusion?
• For anything we reduce, how would it be done, and what should we watch for?
• If a medicine is stopped and a problem returns, what is the plan?

These keep the conversation collaborative. You are not telling the doctor a medicine is wrong. You are asking for a deliberate look, which is exactly what deprescribing is.

Why "stopping" is a clinical act, not a household one

It is tempting, once a medicine looks unnecessary, to just stop refilling it. Resist that. Some medicines must be reduced gradually, and stopping them abruptly can cause withdrawal effects or a rebound of the original condition. This is precisely why deprescribing is clinician-led and usually staged: a plan for tapering, a timeline, and a checkpoint to see how your parent does. Your job is to follow that plan and report what you observe, not to compress it.

Which medicines tend to come up in a review

You are not the one who decides what gets reduced, but it helps to know the kinds of medicines that often draw a closer look so your records are ready. Reviews frequently examine medicines that act on the brain, which is the heart of the NIA's concern about three or more CNS-active drugs and their link to falls and memory problems: certain sleep aids, sedatives, and some pain medicines fall here. This connects to a wider risk: the CDC notes that more than 1 in 4 older adults falls each year, so a regimen's effect on steadiness is a fair thing to raise in a review. Reviews also look at medicines started long ago whose original reason has passed, medicines preventing a problem that may no longer be the priority given the person's overall situation, and any drug that seems to be treating the side effect of another drug.

For each of these, your job is the same: have the purpose, the start date if known, and any side-effect history written down. That turns a vague "does she still need this?" into a specific, answerable question the clinician can work with. You are supplying the evidence, not the verdict.

How a planned reduction usually unfolds

When a clinician does decide to reduce or stop a medicine, the process is usually deliberate, and knowing the rhythm helps you support it without rushing. Often the medicine is tapered in steps rather than stopped at once, with a timeline and a checkpoint to see how your parent does at each stage. The clinician will usually tell you what to watch for: the return of the original symptom, or a withdrawal effect specific to that drug. Your role is to observe and report at the agreed points, keeping a short note of how your parent is doing so the next conversation works from observation rather than memory.

This is also where the MedlinePlus habit of writing down the plan pays off. A clear note of "reduce in two steps over six weeks, watch for X, call if Y" keeps everyone aligned and prevents a well-intended reduction from quietly becoming an abrupt stop. If the original problem returns, that is information for the clinician, not a failure, and often the plan simply adjusts.

Report promptly to the care team if, after any planned medicine reduction, the original symptoms return or new ones appear, such as worse pain, mood changes, sleep disruption, or unsteadiness. Severe withdrawal effects, chest pain, fainting, or a seizure are emergencies. Call emergency services rather than waiting.

A deprescribing-prep checklist

• [ ] Complete medicine list assembled, including OTC products and supplements.
• [ ] Each medicine's current purpose noted, with temporary ones flagged.
• [ ] Side-effect and reaction history written down.
• [ ] Medicines your parent already skips or dislikes noted.
• [ ] Your parent's own goals captured, if they have any.
• [ ] Three to five collaborative questions written for the prescriber.
• [ ] A shared understanding that any change will be clinician-led and monitored.

What not to ask AI to do here

A tool can help you organize the list, surface which medicines look temporary, and draft questions for a review. It cannot decide that a medicine should be stopped, cannot design a taper, and cannot predict how a specific person will respond to a change. Acting on an app's suggestion to stop a drug, instead of a prescriber's supervised plan, can be dangerous. Use the tool to prepare the conversation, and leave the decision with the clinician.

Make a doctor brief

Create a caregiver doctor brief to bring your parent's full medicine list, side-effect history, and review questions into one place, so a deprescribing conversation starts organized and stays clinician-led.